Literature DB >> 26766146

Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities.

Beatriz Larru1, Wu Gong, Neika Vendetti, Kaede V Sullivan, Russell Localio, Theoklis E Zaoutis, Jeffrey S Gerber.   

Abstract

BACKGROUND: Bloodstream infection is a major cause of morbidity and mortality. Much of our understanding of the epidemiology and resistance patterns of bloodstream infections comes from studies of hospitalized adults.
METHODS: We evaluated the epidemiology and antimicrobial resistance of bloodstream infections occurring during an 11-year period in a large, tertiary care children's hospital in the US. All positive blood cultures were identified retrospectively from clinical microbiology laboratory records. We excluded repeat positive cultures with the same organism from the same patient within 30 days and polymicrobial infections.
RESULTS: We identified 8196 unique episodes of monomicrobial bacteremia in 5508 patients. Overall, 46% were community onset, 72% were Gram-positive bacteria, 22% Gram-negative bacteria and 5% Candida spp. Coagulase negative Staphylococcus was the most common isolated organism. ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) accounted for 20% of episodes. No S. aureus isolate was resistant to vancomycin or linezolid, and no increase in vancomycin minimum inhibitory concentration among methicillin-resistant S. aureus was observed during the study period. Clinically significant increases in vancomycin-resistant Enterococcus, ceftazidime-resistant P. aeruginosa or carbapenem-resistant Enterobacteriaceae were not observed during the study period; however, rates of methicillin-resistant S. aureus increased over time (P < 0.01).
CONCLUSIONS: Gram-positive and ESKAPE organisms are leading causes of bacteremia in hospitalized children. Although antimicrobial resistance patterns were favorable compared with prior reports of hospitalized adults, multicenter studies with continuous surveillance are needed to identify trends in the emergence of antimicrobial resistance in this setting.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26766146     DOI: 10.1097/INF.0000000000001057

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study.

Authors:  N Buetti; A Atkinson; L Kottanattu; J Bielicki; J Marschall; A Kronenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-24       Impact factor: 3.267

2.  Functional consequences of B-repeat sequence variation in the staphylococcal biofilm protein Aap: deciphering the assembly code.

Authors:  Catherine L Shelton; Deborah G Conrady; Andrew B Herr
Journal:  Biochem J       Date:  2016-11-21       Impact factor: 3.857

3.  What's new in PICU in resource limited settings?

Authors:  Andrew C Argent; Mohammod J Chisti; Suchitra Ranjit
Journal:  Intensive Care Med       Date:  2017-09-14       Impact factor: 17.440

Review 4.  Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance.

Authors:  Laura Folgori; Julia Bielicki
Journal:  J Pediatr Intensive Care       Date:  2019-01-17

5.  Early Bayesian Dose Adjustment of Vancomycin Continuous Infusion in Children: a Randomized Controlled Trial.

Authors:  Romain Berthaud; Sihem Benaboud; Déborah Hirt; Mathieu Genuini; Mehdi Oualha; Martin Castelle; Coralie Briand; Solène Artru; Lorenzo Norsa; Olivia Boyer; Frantz Foissac; Naïm Bouazza; Jean-Marc Tréluyer
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

6.  A Multicenter Analysis of Changes in Pediatric Antibiotic Susceptibilities Among Staphylococcus aureus and Pseudomonas aeruginosa Isolates: 2014-2018.

Authors:  Jeremy S Stultz; Emily Benefield; Kelley R Lee; Ferras Bashqoy; Amy L Pakyz
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09

7.  A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures.

Authors:  Angela Fimbres Veesenmeyer; Jared A Olson; Adam L Hersh; Chris Stockmann; Kent Korgenski; Emily A Thorell; Andrew T Pavia; Anne J Blaschke
Journal:  Infect Dis Ther       Date:  2016-11-10

Review 8.  Manipulating the microbiome: evolution of a strategy to prevent S. aureus disease in children.

Authors:  D F Khamash; A Voskertchian; A M Milstone
Journal:  J Perinatol       Date:  2017-11-09       Impact factor: 2.521

9.  Bactericidal Effect of Photodynamic Therapy, Alone or in Combination with Mupirocin or Linezolid, on Staphylococcus aureus.

Authors:  Vanesa Pérez-Laguna; Luna Pérez-Artiaga; Verónica Lampaya-Pérez; Isabel García-Luque; Sofía Ballesta; Santi Nonell; Manuel P Paz-Cristobal; Yolanda Gilaberte; Antonio Rezusta
Journal:  Front Microbiol       Date:  2017-05-31       Impact factor: 5.640

Review 10.  Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

Authors:  Juwon Yim; Leah M Molloy; Jason G Newland
Journal:  Infect Dis Ther       Date:  2016-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.